These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23754941)

  • 21. A single amino acid substitution in HIV-1 reverse transcriptase significantly reduces virion release.
    Chiang CC; Wang SM; Pan YY; Huang KJ; Wang CT
    J Virol; 2010 Jan; 84(2):976-82. PubMed ID: 19889767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo processing of Pr160gag-pol from human immunodeficiency virus type 1 (HIV) in acutely infected, cultured human T-lymphocytes.
    Lindhofer H; von der Helm K; Nitschko H
    Virology; 1995 Dec; 214(2):624-7. PubMed ID: 8553565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Placement of leucine zipper motifs at the carboxyl terminus of HIV-1 protease significantly reduces virion production.
    Pan YY; Wang SM; Huang KJ; Chiang CC; Wang CT
    PLoS One; 2012; 7(3):e32845. PubMed ID: 22396796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human immunodeficiency virus type 1 (HIV-1) protein Vif inhibits the activity of HIV-1 protease in bacteria and in vitro.
    Kotler M; Simm M; Zhao YS; Sova P; Chao W; Ohnona SF; Roller R; Krachmarov C; Potash MJ; Volsky DJ
    J Virol; 1997 Aug; 71(8):5774-81. PubMed ID: 9223465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retroviral proteases and their roles in virion maturation.
    Konvalinka J; Kräusslich HG; Müller B
    Virology; 2015 May; 479-480():403-17. PubMed ID: 25816761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Direct Interaction with RNA Dramatically Enhances the Catalytic Activity of the HIV-1 Protease In Vitro.
    Potempa M; Nalivaika E; Ragland D; Lee SK; Schiffer CA; Swanstrom R
    J Mol Biol; 2015 Jul; 427(14):2360-78. PubMed ID: 25986307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation.
    Quillent C; Borman AM; Paulous S; Dauguet C; Clavel F
    Virology; 1996 May; 219(1):29-36. PubMed ID: 8623542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles.
    Karacostas V; Wolffe EJ; Nagashima K; Gonda MA; Moss B
    Virology; 1993 Apr; 193(2):661-71. PubMed ID: 7681610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles.
    Wu X; Liu H; Xiao H; Conway JA; Kappes JC
    J Virol; 1996 Jun; 70(6):3378-84. PubMed ID: 8648668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cryo-EM structure of the HIV-1 Pol polyprotein provides insights into virion maturation.
    Harrison JJEK; Passos DO; Bruhn JF; Bauman JD; Tuberty L; DeStefano JJ; Ruiz FX; Lyumkis D; Arnold E
    Sci Adv; 2022 Jul; 8(27):eabn9874. PubMed ID: 35857464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-Terminal HIV-1 Transframe p6* Tetrapeptide Blocks Enhanced Gag Cleavage Incurred by Leucine Zipper Replacement of a Deleted p6* Domain.
    Yu FH; Huang KJ; Wang CT
    J Virol; 2017 May; 91(10):. PubMed ID: 28250114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcellular Localization of HIV-1
    Becker JT; Sherer NM
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteolytic processing and assembly of gag and gag-pol proteins of TED, a baculovirus-associated retrotransposon of the gypsy family.
    Hajek KL; Friesen PD
    J Virol; 1998 Nov; 72(11):8718-24. PubMed ID: 9765414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations in the HIV-1 reverse transcriptase tryptophan repeat motif affect virion maturation and Gag-Pol packaging.
    Chiang CC; Tseng YT; Huang KJ; Pan YY; Wang CT
    Virology; 2012 Jan; 422(2):278-87. PubMed ID: 22104208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in HIV-1 gag and pol compensate for the loss of viral fitness caused by a highly mutated protease.
    Kozísek M; Henke S; Sasková KG; Jacobs GB; Schuch A; Buchholz B; Müller V; Kräusslich HG; Rezácová P; Konvalinka J; Bodem J
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4320-30. PubMed ID: 22644035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of the Gag-Pol transframe domain p6* and its coding sequence to morphogenesis and replication of human immunodeficiency virus type 1.
    Paulus C; Ludwig C; Wagner R
    Virology; 2004 Dec; 330(1):271-83. PubMed ID: 15527852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of human immunodeficiency virus type 1 Pr55(Gag) and Pr160(Gag-pol) processing intermediates that accumulate in primary and transformed cells treated with peptidic and nonpeptidic protease inhibitors.
    Speck RR; Flexner C; Tian CJ; Yu XF
    Antimicrob Agents Chemother; 2000 May; 44(5):1397-403. PubMed ID: 10770790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteolytic processing of particle-associated retroviral polyproteins by homologous and heterologous viral proteinases.
    Konvalinka J; Heuser AM; Hruskova-Heidingsfeldova O; Vogt VM; Sedlacek J; Strop P; Kräusslich HG
    Eur J Biochem; 1995 Feb; 228(1):191-8. PubMed ID: 7883003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective killing of human immunodeficiency virus infected cells by non-nucleoside reverse transcriptase inhibitor-induced activation of HIV protease.
    Jochmans D; Anders M; Keuleers I; Smeulders L; Kräusslich HG; Kraus G; Müller B
    Retrovirology; 2010 Oct; 7():89. PubMed ID: 20950436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The virion-associated Gag-Pol is decreased in chimeric Moloney murine leukemia viruses in which the readthrough region is replaced by the frameshift region of the human immunodeficiency virus type 1.
    Gendron K; Dulude D; Lemay G; Ferbeyre G; Brakier-Gingras L
    Virology; 2005 Apr; 334(2):342-52. PubMed ID: 15780884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.